Calcineurine : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Calcineurine : Questions médicales les plus fréquentes", "headline": "Calcineurine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Calcineurine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-05", "dateModified": "2026-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Calcineurine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phosphoprotein Phosphatases", "url": "https://questionsmedicales.fr/mesh/D010749", "about": { "@type": "MedicalCondition", "name": "Phosphoprotein Phosphatases", "code": { "@type": "MedicalCode", "code": "D010749", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.559" } } }, "about": { "@type": "MedicalCondition", "name": "Calcineurine", "alternateName": "Calcineurin", "code": { "@type": "MedicalCode", "code": "D019703", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Martha S Cyert", "url": "https://questionsmedicales.fr/author/Martha%20S%20Cyert", "affiliation": { "@type": "Organization", "name": "Department of Biology, Stanford University, Stanford, CA 94035, United States. Electronic address: mcyert@stanford.edu." } }, { "@type": "Person", "name": "Midori Shimada", "url": "https://questionsmedicales.fr/author/Midori%20Shimada", "affiliation": { "@type": "Organization", "name": "Department of Veterinary Biochemistry, Yamaguchi University, 1677-1 Yoshida, Yamaguchi, Yamaguchi, 753-8511, Japan." } }, { "@type": "Person", "name": "Shunsuke Hanaki", "url": "https://questionsmedicales.fr/author/Shunsuke%20Hanaki", "affiliation": { "@type": "Organization", "name": "Department of Veterinary Biochemistry, Yamaguchi University, 1677-1 Yoshida, Yamaguchi, Yamaguchi, 753-8511, Japan." } }, { "@type": "Person", "name": "Makoto Habara", "url": "https://questionsmedicales.fr/author/Makoto%20Habara", "affiliation": { "@type": "Organization", "name": "Department of Veterinary Biochemistry, Yamaguchi University, 1677-1 Yoshida, Yamaguchi, Yamaguchi, 753-8511, Japan." } }, { "@type": "Person", "name": "Wenying Li", "url": "https://questionsmedicales.fr/author/Wenying%20Li", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Conformational regulation and target-myristoyl switch of calcineurin B homologous protein 3.", "datePublished": "2023-07-12", "url": "https://questionsmedicales.fr/article/37435805", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7554/eLife.83868" } }, { "@type": "ScholarlyArticle", "name": "Calcineurin/NFATc1 pathway represses cellular cytotoxicity by modulating histone H3 expression.", "datePublished": "2024-06-26", "url": "https://questionsmedicales.fr/article/38926604", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-65769-9" } }, { "@type": "ScholarlyArticle", "name": "The Effect of Calcineurin Inhibitors on MMPs Activity in Heart and Their Side Effects-A Review of Literature.", "datePublished": "2023-06-18", "url": "https://questionsmedicales.fr/article/37373446", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms241210291" } }, { "@type": "ScholarlyArticle", "name": "The Ca2+/Calmodulin-dependent Calcineurin/NFAT Signaling Pathway in the Pathogenesis of Insulin Resistance in Skeletal Muscle.", "datePublished": "2023-10-24", "url": "https://questionsmedicales.fr/article/37875146", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-2174-7958" } }, { "@type": "ScholarlyArticle", "name": "Calcineurin stimulation by Cnb1p overproduction mitigates protein aggregation and α-synuclein toxicity in a yeast model of synucleinopathy.", "datePublished": "2023-08-24", "url": "https://questionsmedicales.fr/article/37620860", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12964-023-01242-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines et peptides de signalisation intracellulaire", "item": "https://questionsmedicales.fr/mesh/D047908" }, { "@type": "ListItem", "position": 5, "name": "Phosphoprotein Phosphatases", "item": "https://questionsmedicales.fr/mesh/D010749" }, { "@type": "ListItem", "position": 6, "name": "Calcineurine", "item": "https://questionsmedicales.fr/mesh/D019703" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Calcineurine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Calcineurine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Calcineurine", "description": "Comment diagnostiquer une dysfonction de la calcineurine ?\nQuels symptômes indiquent un problème avec la calcineurine ?", "url": "https://questionsmedicales.fr/mesh/D019703#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Calcineurine", "description": "Quels sont les symptômes d'une inhibition de la calcineurine ?\nLa calcineurine affecte-t-elle le système nerveux ?", "url": "https://questionsmedicales.fr/mesh/D019703#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Calcineurine", "description": "Comment prévenir les effets indésirables des inhibiteurs de la calcineurine ?\nY a-t-il des mesures préventives pour les patients sous calcineurine ?", "url": "https://questionsmedicales.fr/mesh/D019703#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Calcineurine", "description": "Quels médicaments ciblent la calcineurine ?\nComment la calcineurine est-elle impliquée dans les traitements immunosuppresseurs ?", "url": "https://questionsmedicales.fr/mesh/D019703#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Calcineurine", "description": "Quelles complications peuvent survenir avec l'inhibition de la calcineurine ?\nLa calcineurine est-elle liée à des cancers ?", "url": "https://questionsmedicales.fr/mesh/D019703#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Calcineurine", "description": "Quels sont les facteurs de risque d'une dysfonction de la calcineurine ?\nL'âge influence-t-il la fonction de la calcineurine ?", "url": "https://questionsmedicales.fr/mesh/D019703#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction de la calcineurine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des analyses fonctionnelles peuvent évaluer l'activité de la calcineurine." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème avec la calcineurine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme l'immunosuppression ou des troubles neurologiques peuvent survenir." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une inhibition de la calcineurine ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent présenter des infections fréquentes et des troubles neurologiques." } }, { "@type": "Question", "name": "La calcineurine affecte-t-elle le système nerveux ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une inhibition de la calcineurine peut entraîner des effets neurotoxiques." } }, { "@type": "Question", "name": "Comment prévenir les effets indésirables des inhibiteurs de la calcineurine ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier et un ajustement des doses sont essentiels pour minimiser les risques." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives pour les patients sous calcineurine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les infections et surveiller les signes de toxicité est crucial." } }, { "@type": "Question", "name": "Quels médicaments ciblent la calcineurine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les inhibiteurs de la calcineurine comme la ciclosporine et le tacrolimus sont utilisés." } }, { "@type": "Question", "name": "Comment la calcineurine est-elle impliquée dans les traitements immunosuppresseurs ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle est ciblée pour réduire l'activité immunitaire dans les greffes d'organes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'inhibition de la calcineurine ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la néphrotoxicité et l'hypertension peuvent se développer." } }, { "@type": "Question", "name": "La calcineurine est-elle liée à des cancers ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une inhibition prolongée peut augmenter le risque de certains cancers." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'une dysfonction de la calcineurine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de maladies auto-immunes et l'utilisation prolongée d'immunosuppresseurs." } }, { "@type": "Question", "name": "L'âge influence-t-il la fonction de la calcineurine ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter l'activité de la calcineurine et la réponse immunitaire." } } ] } ] }